Keyphrases
Intensity-modulated Arc Radiotherapy
100%
Randomized Phase II Trial
100%
Radiotherapy Dose Escalation
100%
High-risk Neuroblastoma
100%
Radiotherapy Techniques
100%
Dose Escalation
57%
Radiotherapy
42%
At-risk
14%
Dosimetric
14%
Abdominal Neuroblastoma
14%
Kidney
14%
High Risk
14%
Primary Tumor Site
14%
Anterior-posterior
14%
Feasibility Trial
14%
Randomized Phase III Trial
14%
Regional Lymph Nodes
14%
Safe Dose
14%
Planning Target Volume
14%
Volume Coverage
14%
Neuroblastoma
14%
Conventional Techniques
14%
Dosimetric Parameters
14%
Medicine and Dentistry
Phase II Trials
100%
Ganglioneuroblastoma
100%
Radiation Dose Escalation
100%
Radiation Therapy
100%
Pyrazinamide
20%
Primary Tumor
10%
Lymph Node
10%